Method and compounds for treating inflammatory bowel disease
US4312806A · kind A · utility
19Cited by
4References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 1981 |
| Grant date | Jan 26, 1982 |
| Priority date | — |
| Expiry date | Mar 2, 2001 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC09B63/005
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds and a method for the prophylaxis and treatment of Inflammatory Bowel Disease (IBD) via the administration of an effective amount in a suitable pharmaceutical dosage form of an azobenzene compound of formula I or a pharmacologically acceptable salt, which is reductively cleaved to 5-aminosalicylic acid (5-ASA) by bacteria in the large intestine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.